Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CADM1 , MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer

3 Oct 2014

Abstract excerpt

AIMS: Gene promoter hypermethylation is recognised as an essential early step in carcinogenesis, indicating important application areas for DNA methylation analysis in early cancer detection. The current study was set out to assess the performance of CADM1, MAL and miR124-2 methylation analysis in cervical scrapes for detection of cervical and endometrial cancer. METHODS: A series of cervical scrapes of women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Gestational Trophoblastic Disease Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25281766
DOI: 10.1136/jclinpath-2014-202616

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CADM1 , MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancerPMID 25281766Read ↗

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity Read ↗

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide studySemantic proximity Read ↗

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3Semantic proximity Read ↗

Evaluation of Six Methylation Markers Derived from Genome-Wide Screens for Detection of Cervical Precancer and CancerSemantic proximity Read ↗

Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer PreventionSemantic proximity Read ↗

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.Semantic proximity Read ↗

The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapingsSemantic proximity Read ↗

DNA methylation for cervical cancer screening: a training set in ChinaSemantic proximity Read ↗

Performance of DNA methylation‐based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility studySemantic proximity Read ↗

Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A reviewSemantic proximity Read ↗

Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaSemantic proximity Read ↗

Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.